These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17079242)

  • 1. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
    Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
    J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
    Geller BL; Deere J; Tilley L; Iversen PL
    J Antimicrob Chemother; 2005 Jun; 55(6):983-8. PubMed ID: 15872045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
    Tilley LD; Hine OS; Kellogg JA; Hassinger JN; Weller DD; Iversen PL; Geller BL
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.
    Tan XX; Actor JK; Chen Y
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3203-7. PubMed ID: 16048926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo.
    Mellbye BL; Weller DD; Hassinger JN; Reeves MD; Lovejoy CE; Iversen PL; Geller BL
    J Antimicrob Chemother; 2010 Jan; 65(1):98-106. PubMed ID: 19884121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
    Mellbye BL; Puckett SE; Tilley LD; Iversen PL; Geller BL
    Antimicrob Agents Chemother; 2009 Feb; 53(2):525-30. PubMed ID: 19015356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
    Deere J; Iversen P; Geller BL
    Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
    Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
    Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.
    Geller BL; Deere JD; Stein DA; Kroeker AD; Moulton HM; Iversen PL
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3233-9. PubMed ID: 14506035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer.
    Mitev GM; Mellbye BL; Iversen PL; Geller BL
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3700-4. PubMed ID: 19581453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
    Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
    Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
    Moulton HM; Fletcher S; Neuman BW; McClorey G; Stein DA; Abes S; Wilton SD; Buchmeier MJ; Lebleu B; Iversen PL
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):826-8. PubMed ID: 17635157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.
    Greenberg DE; Marshall-Batty KR; Brinster LR; Zarember KA; Shaw PA; Mellbye BL; Iversen PL; Holland SM; Geller BL
    J Infect Dis; 2010 Jun; 201(12):1822-30. PubMed ID: 20438352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.
    Amantana A; Moulton HM; Cate ML; Reddy MT; Whitehead T; Hassinger JN; Youngblood DS; Iversen PL
    Bioconjug Chem; 2007; 18(4):1325-31. PubMed ID: 17583927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.
    Puckett SE; Reese KA; Mitev GM; Mullen V; Johnson RC; Pomraning KR; Mellbye BL; Tilley LD; Iversen PL; Freitag M; Geller BL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6147-53. PubMed ID: 22985881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL; Arora V; Acker AJ; Mason DH; Devi GR
    Clin Cancer Res; 2003 Jul; 9(7):2510-9. PubMed ID: 12855625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.
    Szabo D; Ostorhazi E; Binas A; Rozgonyi F; Kocsis B; Cassone M; Wade JD; Nolte O; Otvos L
    Int J Antimicrob Agents; 2010 Apr; 35(4):357-61. PubMed ID: 20031377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers.
    Kinney RM; Huang CY; Rose BC; Kroeker AD; Dreher TW; Iversen PL; Stein DA
    J Virol; 2005 Apr; 79(8):5116-28. PubMed ID: 15795296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.